ArticleDigestive diseases and sciences2022
No Evidence Indicates Famotidine Reduces the Risk of Serious Disease in COVID-19 Patients After Propensity Score Matching: Meta-Analysis and Systematic Reviews.
Weizheng Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.